Cigarette and alcohol use at historic low among teens

Cigarette and alcohol use by eighth, 10th and 12th-graders are at their lowest point since the Monitoring the Future (MTF) survey began polling teenagers in 1975, according to this year’s survey results. However, this positive news is tempered by a slowing rate of decline in teen smoking as well as continued high rates of abuse of other tobacco products (e.g., hookahs, small cigars, smokeless tobacco), marijuana and prescription drugs. The survey results appeared to show that more teens continue to abuse marijuana than cigarettes; and alcohol is still the drug of choice among all three age groups queried. MTF is an annual survey of eighth, 10th, and 12th-graders conducted by researchers at the University of Michigan, Ann Arbor, under a grant from NIDA. Read more ⇒

News from this year’s survey was announced December 14th during a press conference in Washington, D.C. NIDA Director Dr. Nora Volkow presented the survey results, and was joined by ONDCP Director Gil Kerlikowske, Assistant Secretary for Health at HHS Dr. Howard Koh, and Principal Investigator Dr. Lloyd Johnston. Media coverage of the event was extensive, reaching more than 41 million viewers. The national network placements included ABC World News TonightCBS Evening News,PBS Newshour, and NBC Nightly News with Brian Williams. National cable placements included CNN Health and several others. Locally, stories ran in all of the top 50 markets, including multiple stations in the top 10 markets. Print coverage included 375 articles, including USA TodayAssociated PressUPI.comNew York TimesLos Angeles TimesReutersWashington PostNational JournalTimeEducation Week, and HealthDay. Additionally, there were close to 300 tweets posted about the survey.Listen to the audiocast of the press conference ⇒View additional information on the MTF survey ⇒


Time for Recovery’s Close Up

Addiction has become a hot topic in media coverage, given the on-again, off-again escapades of celebrity addicts, and the popularity of reality television’s Celebrity Rehab with Dr. DrewSober House,Intervention and Addicted. Apparently, addiction sells, or at least the drama and nail-biting narrative that often accompanies it.

On the up side, such attention has raised awareness of the disease and may even prove an aid in its prevention. The down side: perpetuation of the ugly stigma of addiction and the neglect of its prettier-yet-not-as-compelling counterpart, recovery.

During a recent phone interview with Dr. Drew Pinsky of Celebrity Rehab fame, I asked how he answered the criticism that his television shows promote stigma by focusing on fallen D-listers at their most vulnerable and volatile. “Look at the objective reality,” he said. “We have raised awareness of the nature of addiction, how common addiction is, how it doesn’t discriminate. We have pulled the curtain back on this mysterious thing called treatment.”

Pinsky communicated a real concern for educating the public about addiction and treatment and using whatever means in his power to reach the widest audience. He believes the portrayal of addiction and recovery in the media is getting better. “It’s just getting more accurate, more realistic.”  He also notes that Celebrity Rehabfollows each season’s patients in Celebrity Rehab Revisited, to underscore the possibility and promise of recovery.

And realistic it is: some of the show’s stars have relapsed, some have succumb to the disease (former Alice in Chains bassist and one of the show’s graduates, Mike Starr , died last March), and some have gone on to lead healthy, happy lives. Such is the nature of addiction and recovery and Pinsky cannot be faulted for presenting addiction as the cunning, baffling, and ugly foe it is.

Still, media coverage of substance addiction recovery and all its glory is spotty, at best. Television leans toward the sensational and seedy side of addiction, while scores of radio shows, both traditional and web-based, provide news and views on addiction, treatment information and fellowship opportunities, but largely ignore the benefits and maintenance of a recovery lifestyle and fail to impact the larger public consciousness.

Yes, we’ve moved away from those lovable portrayals of family drunks on the big screen (think Uncle Billy in It’s a Wonderful Life) in favor of exacting portraits of addiction (Ray28 DaysWalk the Line), but few films follow the narrative arc past the addict’s redemption or demise to explore recovery’s happy ending. Exceptions have sprouted in both print and digital media. Some bright spots on the horizon are the webcasts fueled by the search engine powerhouse, YouTube. Recovery Community Organizations (RCOs) such as Minnesota Recovery Connection report utilizing YouTube to upload video of their recovery events to promote advocacy and, says Executive Director Nell Hurley, allow the general public “to see the reality of recovery.” Original web programs such as “Recovery Now” produced by RecoveryNowTV.com highlight the possibility of recovery by following the stories of addicts before and after their recovery journey.

Such a window into the wonderful world of recovery shows promise, but is largely overshadowed by the mountain of preventative and educational programming on addiction and treatment provider promotions. And it is still unclear just how many viewers are actually tuning in on a regular basis, or who those viewers are. Such programming may prove to be a wonderful tool for prevention and intervention, and especially good at connecting addicts or their loved ones to treatment options, but again, leaves little or no impression on a public that continues to marginalize active and recovering addicts.

As the former editorial director of Renew magazine, the only national recovery lifestyle publication, I was reminded by the grateful communications from our readers that there is a healthy and hungry audience for positive recovery messages. But our work has just begun. If we are to diminish addiction’s stigma while also conveying to addicts still suffering that the future does indeed hold promise, we must effectively communicate the positive, empowering, transformative nature of recovery across all media and in a way that engages all audiences.

I recently asked retired General Barry McCaffrey what he had learned in his many years as an advocate for addiction prevention. The former director of the U.S. Office of National Drug Control Policy immediately offered his impression of the recovery community as a lesson he had learned and hoped to share.

“What I’ve found that has been consistent for 15 years is, the recovery community is a place of charity and kindness and optimism and hope and lack of violence,” McCaffrey said. “And it’s people who have been in abject misery and now their struggling to be free. So lesson number one that I’ve learned is, it’s an incredibly uplifting experience and an honor to work for the recovering community.”

Cut. Print. Wrap.


What to read after you’ve stopped drinking

Jim Moorhead launched Renew in the right town. When his magazine starts to grow he’ll want to add writers and editors. And there’s no shortage in Chicago of first-rate, experienced journalists in recovery.

Not that a history of substance abuse is a requirement for working atRenew, but it helps in journalism to know the kind of life you’re writing about. “I am a high-functioning, high-low alcoholic,” Moorhead’s first editor, Kelly O’Rourke Johns, wrote in Renew two issues ago. (She’s since moved on. Her successor is also in recovery.) “It took me a long time to admit such a thing and certainly to admit it to a doctor.” A “high-low,”Renew informed me, is a drunk who has trouble recognizing that she’s hit bottom because it looks so much like a top. “Never subjected to DUIs or jail time or any real, harsh consequences,” Johns continued, “high-lows often take a long time to recognize they have a problem and have a tough time convincing others once they do.”

Written for addicts in recovery, Renew could be described as niche journalism except that “niche”profoundly understates the potential audience. According to studies I was shown by professor Deborah Hasin, an epidemiologist at Columbia University, there are some 23.5 million substance-dependent Americans who have stayed clean for the past year or longer. Moorhead tells me that according to the federal Department of Health and Human Services, 20 million Americans are in recovery and another 23 million need help. What’s more, says Moorhead, “for every addict or alcoholic there are four other people affected by it.”

Who doesn’t have a drunk or substance abuser somewhere in his life? The market is all of us.

Alison True, the former editor of the Reader, knows Moorhead through the Near North Montessori School, where her husband teaches. Moorhead’s daughter is a student there. (Her teacher, incidentally, is my daughter.) True is familiar with Moorhead’s plans and she thinks Renew can succeed for the same reason the Reader did. “We used to say, ‘Who reads the ReaderReader readers are people who read the Reader,’” True tells me, sharing an insight that might sound like a mindless tautology and is anything but. “He can’t capture the 20 million people in recovery. He can capture the people in recovery who want to identify as people in recovery.” In other words, Renew can create the audience waiting to be formed as soon as a magazine came along to form it.

And think of those hard-charging high-lows. The advertising Renew carries after a mere year of existence is largely for treatment centers. “It’s the low-hanging fruit,” says Moorhead. But Renew is a slick, oversize, coffee-table sort of magazine, and he covets the sort of high-end ads that celebrate desirable lifestyles. Right now he prints 20,000 copies of each issue, distribution is primarily through treatment centers, and he has about 5,000 subscribers. But he talks about 100,000. And he believes that when advertisers look twice they’ll recognize that these are consumers redefining their lives and willing to spend money to do it. “Entering recovery is no different than getting married, or having a first child,” says Moorhead. “It’s entering a new life stage. My experience is that when you turn your life around you start to reevaluate everything. You make decisions that support your new life, whether it’s exercising, or eating well—it goes on and on.”

Moorhead publishes Renew every two months and his goal is to make it a monthly. He wants his website,RenewEveryDay.com, to become the go-to site for anyone in recovery—the place to find a therapist or an AA meeting, or to organize a softball team, or to locate a restaurant that won’t seat you in the bar or drench your dessert in liqueur, or to turn to for help if you’ve got a teenager at home who’s in trouble.

As folks in recovery are wont to say, Moorhead’s solution to his problems growing up turned out to be a bigger problem. He was a shy and lonely teenager in Lake Forest, but the summer before his junior year of high school he went to a party, got drunk, and woke up the next morning “with this exhilarating feeling that it had been a great night even though I couldn’t remember much of it. Fast forward. I suddenly became very popular. I started dating the captain of the cheerleading squad.”

But when he went off to college he was an outsider again, and this time booze got him into fights and eventually kicked out of school. His father published some medical magazines and Moorhead joined him in the business. “We butted heads a lot,” he says. “We got along best when we were both drinking.” Along the way, he added cocaine to the mix.

Ten years ago his dad sold off the last of the magazines. Newly married, Moorhead needed a job but wasn’t looking for one. “My disease of alcohol addiction really took off,” he says. He tried an outpatient program at Northwestern Hospital. “That didn’t take.” He sampled a 12-step program. “I went back to my old ways.” Friends cornered him at a wedding and made him admit he needed help, but his visits to a series of treatment centers did him no lasting good. Then he heard about an “alternative treatment” in Arizona. “When I was there I didn’t talk about addiction—I talked about childhood trauma, something I never thought I had to address. I said, ‘Guys, I don’t think I belong here.’ But in the end it was really cool. I was able to draw connections, like lights going off in my head.”

Meanwhile, “being a publishing guy, I was always looking for magazine resources supporting people in recovery.” Titles would come and go, he says, but they all sent the wrong message: “I’m in recovery and this is all I deserve.” Moorhead imagined a magazine that flatly rejected the shame and stigma of recovery, and two years ago he decided to create it himself. After raising $700,000 from investors, he was in business.

Sitting there on your coffee table, Renew doesn’t shriek at you to never forget you’re one drink from oblivion. Rather, it proclaims you as someone saying yes to yourself and yes to life. On the cover of the September/October issue a radiant young blond woman in jeans kneels in a gold-spangled field. She’s at one with nature. On the cover of the November/December issue an elegant chatelaine stands by a table perfectly set. She’s at one with wealth and culture. The first is Tara Conner, the former Miss USA who, the cover tells us, “faced down addiction . . . to find her inner beauty.” The second is Brenda Wilhelmson, author of Diary of an Alcoholic Housewife, who “dishes about shame, friendships and why she outed herself.”

What is more familiar than the sight of a beautiful celebrity once stained by scandal now celebrating her triumphant quest “to find her inner beauty”? As for headlines that announce “Reinvent Yourself in 2012″ and “Conquering Self-Esteem”—Renew, meet Cosmo and O. I ask Moorhead if he has any trouble finding glamorous people in recovery who are willing to put themselves out there publicly. “For everyone who’s not interested, there are two or three who are,” he says.

And do celebrities ever approach Renew to let it be known they would not say no if asked to share the inspirational details of their personal struggle?

“We had a few like that,” Moorhead allows.

From LA?

“Exactly.”

When Hollywood notables dry out, word gets around. Reporters in recovery are known mostly to other reporters in recovery, and reporters who should be in recovery to their anguished friends. But in this business, alcoholism doesn’t so much go unseen as unconfronted. Perhaps out of a delusional loyalty to romanticized traditions, we tend not to judge or intervene.

But not being stoned and pilloried doesn’t save a drunk from destroying his life and career. Sometimes it just greases the skids. Renew treats the dark side of addiction with a light hand, but Moorhead says his readers understand what’s at stake. As he says about his own life in recovery, “If I lose this I lose everything. If it was to happen again I can only imagine what would happen next. Most significantly, I know I would die. I’d lose my wife. I’d lose my daughter. My job, my business, everything would fail.”


Press Clip From Renew Magazine


Office of National Drug Control Policy Releases Northern Border Drug Control Strategy

New Strategy to Supplement Existing Obama Administration Initiatives Working to Reduce Demand for Drugs in the United States; Balance Drug Prevention, Treatment, and Law Enforcement Efforts

Washington, D.C. – Today, Gil Kerlikowske, Director of National Drug Control Policy, released the Obama Administration’s first-ever National Northern Border Counternarcotics Strategy. The Strategy outlines new actions that seek to reduce the two-way flow of illicit drugs between the United States and Canada by increasing coordination among Federal, state, local, and tribal enforcement authorities, enhancing intelligence sharing between counterdrug agencies, and strengthening ongoing counterdrug partnerships and initiatives with the Government of Canada and the Royal Canadian Mounted Police (RCMP).

“Our shared border—which separates two friendly nations with a long history of social, cultural, and economic ties—demands a specific strategy to confront the unique threats presented by illegal drug trafficking,” said Director Kerlikowske. “Drug use and its consequences are significant threats to the public health and safety of communities in both the United States and Canada. As we work to emphasize drug prevention, treatment, and recovery initiatives in the United States, we must ensure that we also build and expand upon existing initiatives that work to protect public safety and health along our Northern border by disrupting drug trafficking.”

“Disrupting the flow of illegal drugs across our borders is critical to our nation’s safety and security,” said Secretary of Homeland Security Janet Napolitano. “I look forward to continuing to work closely with our Canadian partners to strengthen security along the Northern border while facilitating legal travel and trade.”

Ecstasy and marijuana are common drug threats to the United States from Canada, while the United States remains the primary transit country for cocaine into Canada from South America. The National Northern Border Counternarcotics Strategy provides an overview of current counterdrug efforts and identifies supporting actions aimed at disrupting this cross-border flow of illegal drugs. Some key strategic objectives outlined in the Strategyinclude:

- Enhancing coordination of intelligence collection among the U.S. Federal, state, local, tribal and Canadian law enforcement agencies with Northern border counternarcotics responsibilities.

- Increasing the amount seized of illicit narcotics and drug proceeds crossing the Northern border by bolstering security at and between ports of entry.

- Enhancing air and maritime domain awareness and response capabilities along the Northern Border.

- Developing resources and providing training opportunities to tribal law enforcement agencies.

- Targeting the financial infrastructure of Transnational Criminal Organizations and increasing judicial cooperation with the Government of Canada.

ONDCP is coordinating an unprecedented government-wide public health and safety approach to reduce drug use and its consequences in the United States. In addition to the enforcement-focused actions in this Strategy, the Administration recognizes the important role prevention and treatment play in reducing the demand for drugs and creating healthier communities. Overall drug use in the United States has dropped substantially over the past thirty years. More recently, cocaine use has dropped by 40 percent, and meth use in America has been cut by half.  To build on this progress and support the public health approach to drug control outlined in the National Drug Control Strategy, the Obama Administration has committed over $10 billion to drug prevention programs and support for expanding access to drug treatment for people with substance use disorders.

For more information or to read the full Strategy visit:

http://www.whitehouse.gov/ondcp/northern-border-strategy


Martin Luther King Day At Pasadena Recovery Center

L-R Michael Bloom, Alison Triessl, Mrs. Tobie Bloom, Dr. David Smith

Eleven years ago on Martin Luther King Day the Pasadena Recovery Center opened it’s doors and admitted it’s first client.  Founded by psychiatrist Dr. Lee Bloom, his daughter, Alison Triessl and his son, Michael Bloom, the Pasadena Recovery Center has always been dedicated to providing compassionate, comprehensive and affordable treatment to those suffering from chemical dependency.  Today marked the center’s 11th anniversary and to celebrate the occasion a special luncheon was held.  Distinguished guest speakers Dr. David Smith, founder of the Haight-Ashbury Free Clinic and noted expert on addiction, and Dr. Matthew Torrington discussed advances in addiction treatment with 50 plus guests who gathered at the center.


RSVP Today! Pasadena Recovery Network Luncheon – January 16, 2012


Pasadena Rehab Centers Get Addiction Sufferers Back On Track

Maybe it’s the city’s proximity to Hollywood and other entertainment centers throughout Greater Los Angeles — where high populations and the availability of narcotics could potentially encourage alcoholism and drug use — that acco

unts for all the addiction treatment options in Pasadena.

Maybe it’s that people looking to start their lives over inherently need to get away from it all and find respite here that can’t be found anyplace else.

Whatever the reason, there are so many treatment options and philosophies being employed in Pasadena that anyone struggling in isolation with addiction can find his or her way home again.

The journey to recovery is long and can only begin when a person is honestly ready to change his or her life, says Mark Paquet, admissions director for Pasadena’s Impact Drug & Alcohol Treatment.

Six years later, Paquet’s bad habits had progressed from cocaine to crack. He lost his job; that’s when life as he knew it began to devolve.

“I got to the point where I was unemployed, and I was living with my parents again,” he recalls. “When you can’t hold a job, and you can’t afford to pay your rent and you’re just addicted, you can’t do anything else.”

After being arrested for stealing from his own neighbors, Paquet came to Pasadena’s Impact House, which had an in-custody program that allowed him to finally get the help he needed.

Impact uses a multilevel approach that includes acute and sub-acute detox programs as well as in-patient treatment and its connection to Alcoholics Anonymous and Narcotics Anonymous groups operating locally. Impact helps reintegrate clients back into society through its outpatient programs.

Today, Paquet is 16 years drug free and helps others taking the first tentative steps toward sobriety. As an admissions director and a recovering addict, Paquet knows when a person is truly ready.

Impact House, located at 1680 N. Fair Oaks Ave., Pasadena, ((323) 681-2575/impacthouse.com) is one of several local facilities with outpatient and residential treatment options in addition to group, individual and follow-up counseling. Here are other local centers

Pasadena Recovery Center — Despite its reputation for being a place for recalcitrant celebs down on their luck and its being featured prominently onVH1’s “Celebrity Rehab” with Dr. Drew Pinsky, this recovery center has helped thousands of people since the late psychiatrist Dr. Lee Bloom founded it in the 1970s. Today, the facility continues Bloom’s tradition of holistic healing with 12-step programs, counseling, residential services and mind-body activities. Located at 1811 N. Raymond Ave., Pasadena. Call (866) 663-3030 or visit pasadenarecoverycenter.com.

Eaton Canyon Treatment Center — An accredited treatment estate, 3323 Fairpoint St. in Pasadena, this center focuses on creating individualized treatment plans for men and women. The belief is that addiction is a treatable condition, so clients receive a personal consultation upon admission to determine individual needs and goals. Call (888) 798-0150 or visit eatoncanyon.org.

Walter Hoving Home (for women) — A nonprofit residential facility for women 18 and over incorporates a spiritual approach to sober living in a 12-month program. Women attend regular individual and group counseling sessions, day classes, a daily work program and extracurricular activities. Located at 127 S. El Molino Ave., Pasadena. Call (626) 405-0950 or visit walterhovinghome.com.

The Gooden Center (for men) — This accredited drug and alcohol treatment center guides adult men and their families through the painful process of detoxification and long-term sobriety. A 12-step recovery process addresses the psychological, spiritual and emotional underpinnings of addiction. Men attend residential or day treatment programs before transitioning to an intensive outpatient rehabilitation center or sober living home. Located at 191 N. El Molino Ave. Pasadena. Call (626) 356-0078 or visit goodencenter.org.

SOURCE


Bad Medicine

Big Pharama wants to put as many drugs in as many households as possible — whether they’re needed or not

Some people remember 1982, when some twisted humanoid put cyanide into extra-strength Tylenol capsules and killed seven people.

Well, forget about 1982. Today the danger is not from some sociopath lacing pills with poison, but from the drug companies themselves.

Big Pharma
“Iatrogenic” is a great Scrabble word, but it’s also one that you should remember if you or your kids see doctors or take prescription drugs. It means: induced inadvertently by a physician or medical treatment, including prescription medications. If, in the course of a procedure, a doctor nicks an artery and you die, that is an iatrogenic accident. If your son gets the antidepressant Wellbutrin for his bipolar disorder and he commits suicide in a manic psychosis, that too is an iatrogenic “event,” as the drug companies call it.

Each year in the United States, as many as 225,000 deaths are iatrogenic, making it the third leading cause of death. The prestigious Journal of the American Medical Association (JAMA) reports that about 106,000 deaths per year are from “non-error, adverse” effects of prescription meds, making this the fourth leading cause of death in the US. This dwarfs yearly automobile accidents and, in fact, accounts for more deaths than all other accidents combined.

Only heart disease, cancer and strokes kill more Americans than prescription drugs. This shocking figure does not include drugs administered erroneously, nor does it include purposeful overdoses in suicide attempts.

Less deadly but certainly more pervasive is the indiscriminate mindfuck of our kids by the prescription and over-the-counter drug industry, or Big Pharma. Because, unlike the old days of “miracle” drugs and “better living through chemistry,” the name of the game now is profits and indiscriminate placement of as many drugs in as many households (and young bodies and minds) as possible.

It only takes one diagnosis
As a student at Montalvo Elementary and Balboa Middle schools in Ventura, Kelli (not her real name) says she “always kept to myself, couldn’t pay attention and had no friends,” although she did well in English and graduated from high school. At home, “because my father was emotionally abusive and in a constant rage, I stayed in my room and read. … It got to the point where my teachers begged my parents to get me on some kind of drug for what they called my ADD and depression.”

So Kelli’s childhood was an endless array of tests; meds like Prozac, Zoloft, Paxil, Effexor, Cymbalta, Xanax, Zyprexa, Adderall, Dexedrine and Ritalin; therapists; counselors; diagnoses. One diagnosis led to another and Kelli has been at various times diagnosed with clinical depression, attention deficit disorder (ADD), bipolar disorder, generalized anxiety disorder and borderline personality disorder (BPD).

There is no valid chemical test for any of these things. The diagnoses are completely subjective.

From the age of 11, Kelli used alcohol, speed, cocaine and marijuana, and at 13 began to “cut” (use razor blades to inflict small non-suicidal wounds), and binge and purge on food.

Kelli’s most recent diagnosis in 2004 was borderline personality disorder, and after that she was prescribed three more drugs — even though many experts believe borderline personality disorder does not respond to drug therapy. A borderline person is constantly crossing the “borderlines” between psychosis, neurosis and normalcy, and it’s difficult to pinpoint which condition to treat.

Throughout all this, Kelli was never given the one diagnosis that trumps all others: polysubstance dependence, or addiction to several drugs at once. Experimentation with illegal and non-prescribed drugs was described by her therapists as “self-medication,” but no one thought to use this diagnosis and get her off the drug merry-go-round.

Today Kelli takes only one drug — a mild dose of the antidepressant Wellbutrin — runs marathons, attends support groups like Narcotics Anonymous and has a job as a drug counselor. She has not had a drug or drink or cut or purged in three years.
“The single most important thing a psychiatric patient can do is to stop taking illegal and non-prescribed drugs, including alcohol,” says Dr. Lee Bloom, chief psychiatrist at the Pasadena Recovery Center, which is located on North Raymond Avenue and featured in VH1’s “Celebrity Rehab” series. Sometimes, just breaking these habits can undo years of damage, and can be the “cure” for prolonged ailment (if accompanied by a program of support groups and sponsorship) that prescribed drugs are not capable of providing yet.

The blame for Kelli’s fiasco is not all Big Pharma’s — therapists, physicians, parents and school counselors are too often too quick on the diagnosis and prescription trigger. But drug companies are the real culprits in the disgraceful overmedication of our children.

One step forward, two steps back
There was a time when the phrase “miracle drug” meant something. In the 1940s and 1950s, antibiotics, Salk’s polio vaccine, cortisone and potent psychiatric meds such as Thorazine changed and saved lives.

Americans came to believe that Big Pharma was capable of anything, forgetting that these new drugs also had powerful side effects. Antibiotics sometimes actually make people more prone to infection. Cortisone causes gross systemic changes, and Thorazine sometimes turns people into zombies.

Yet there remains a lingering desire to believe that drugs can cure anything, and Big Pharma takes full advantage of that.
Spending on prescription medicines for patients younger than 19 has increased by 85 percent over the past five years, according to an analysis by Medco Health Solutions, a pharmacy benefits management company and subsidiary of the pharmaceutical concern Merck.

Moreover, American children are three times more likely than European children to be prescribed psychotropic medications for conditions such as attention deficit hyperactivity disorder (ADHD) and bipolar disorder, according to a report in the journal Child and Adolescent Psychiatry and Mental Health.

But there’s no evidence that prescription drug-happy societies like ours are doing any better at keeping our kids mentally sound.

In fact, the prosperous, politically influential drug companies may be wreaking havoc on the minds and bodies of our youngsters — turning them into potential drug addicts, predisposing them to look for a chemical solution for every ache or pain when a simple thing like exercise or music often works much better.

In the battle for our children’s minds, drug companies use and oversimplified idea that lulls parents and kids into feeling secure about their drugs: the chemical imbalance theory.

Just a theory
Helping to fuel the current psych-med craze is the almost blind acceptance by doctors, therapists, school counselors and parents of the still-unproven chemical imbalance theory.

The chemical imbalance theory is a useful metaphor, and it is often cited in articles on depression, bipolar disorder, anxiety, obsessive compulsive disorder (OCD), ADD and ADHD. But it is not a valid hypothesis (and the chair of the FDA’s Psychopharmacology Advisory Committee agrees.)

Drug companies would like us to think that psychiatric disorders are the result of a systemic glitch, and that if we take just the right set of psych meds our systems will be restored to a “normal” state and all will be well.

Why do the drug companies use an unproven theory as fact in describing how their drugs work? Because it’s easy for the patient (and the doctor) to understand — and it sounds so … scientific.

Jessica, a 19-year-old patient, describes her situation this way: “I have depression because I don’t have enough serotonin in my body. Serotonin is the chemical that gives people pleasure. My Lexapro contains serotonin, and when I take my Lexapro every day it keeps my serotonin at a constant level and [therefore] keeps my moods consistent.”

That would be a beautiful thing, if we knew it to be true. The official Forest Pharmaceuticals Web site for Lexapro, a commonly prescribed antidepressant, says that people with depression: “Have an imbalance of the brain’s neurotransmitters. …

One of these neurotransmitters is serotonin. An imbalance in serotonin may be an important factor in the development of depression and anxiety. Serotonin is released from one nerve cell and passed to the next. … Selective serotonin reuptake inhibitors block the re-absorption of serotonin. … It is this blocking action that causes an increased amount of serotonin to become available at the next nerve cell.”

You may not understand all that (most therapists and many doctors don’t either) but it certainly sounds impressive. And it’s even better when accompanied by beautiful cartoon drawings and animations of neurotransmitters and synapses.
But the cute cartoons ignore this salient fact: The brain chemistry of depression and anxiety is not fully understood.

“Drug therapy is a little better than witchcraft, but not much. There are at least 100 chemicals in the brain that relate to brain function, and we know something about maybe six of them,” said the Pasadena Recovery Center’s Bloom.

Big Pharma wants us to believe that drugs restore the body to a “normal state.” Almost no drug restores normality. Drugs act on different systems in different and sometimes very powerful ways, and may produce an effect that makes the patient feel better or respond in a positive (or at least positive to their parents or doctor) way.

Think about it. Of all the people you know who have been diagnosed with a “chemical imbalance,” how many were tested chemically to arrive at this diagnosis?

The Diagnostic and Statistical Manual of Mental Disorders, which virtually all psychiatrists and therapists use to diagnose patients, plainly states that the cause of depression and anxiety is “unknown.”

Disease-mongering
According to a report in the Public Library of Science and Medicine, pharmaceutical companies may be inventing diseases in order to drive up their sales figures. Researchers said many conditions “are being medicalized” by the industry.
Restless leg syndrome, a relatively rare condition, is being promoted wildly by Big Pharma “detail men” because there are now drugs for it. Disease awareness campaigns funded by the industry are aimed at “promoting drug sales rather than informing people.”

And although ADD, ADHD, depression and bipolar disorder are valid and serious disorders, Big Pharma has certainly broadened definitions of them by promoting “tests” that nearly guarantee that millions will feel they are suffering from those conditions.

The worst part of the whole fiasco is that you can’t really trust “scholarly” research on the drugs you or your kids might take. Big Pharma at least indirectly funds most studies on emerging drugs, and drug companies are allowed to “throw out” non-supportive studies.

To make matters even worse, some “scholarly” articles are ghostwritten by PR firms employed by drug companies. An April editorial in the Journal of the American Medical Association describes articles penned by Merck and Co. ghostwriters before Merck had eminent academics credited as primary authors. (These articles were about Vioxx, a drug no longer used because it sometimes kills people.)

Today, many drugs are minor variations on old products. The market is filled with astonishingly similar drugs to treat depression, anxiety and bipolar disorder.

For example, the new antidepressant Lexapro, which is more expensive than cocaine, is touted as “a cleaner, improved version” of Celexa. Actually, it differs only slightly (a molecule or two were modified) from the now generically available Celexa. Most doctors won’t tell you that, because Forest Pharmaceuticals gives away a lot of stuff to doctors to persuade them to recommend the more expensive product.

And many drugs are now used for purposes that have little or nothing to do with their original intent. Adderall, for example, is today the most widely used ADHD drug for kids and teenagers. It’s actually four different kinds of speed.

Adderall was derived from the amphetamine-based diet pill Obetrol, no longer used for weight loss because speed is so widely abused. Adderall sometimes helps kids with ADHD to calm down and focus, and many parents celebrate it because it keeps their kids quiet. But it’s still speed.

The good with the bad
To the concerned professional, it sometimes appears that Big Pharma just throws drugs together, and if these don’t kill the first few human guinea pigs, they go on the market.

Despite all the negatives surrounding Big Pharma, however, it must also be said —unequivocally — that drugs save lives and improve the quality of life.

In 1900, a person could expect to live maybe to the age of 50. Today, the average lifespan is nearly 80. In many ways, we Americans are healthier than ever. Better medical care and equipment, better diets and lifestyles, and more knowledge about health all contributed, but much of the credit also goes to pharmaceuticals.

Thousands of people with rheumatoid arthritis, HIV and AIDS, depression (yes, depression) and cancer are alive or living better lives because of prescription drugs. And we don’t even think about polio, diphtheria, malaria and typhoid anymore, thanks to amazing drug cures.

But we must remain concerned about what Big Pharma is doing, and ask whether we are being hoodwinked into taking more drugs than we need, or whether our children are being overmedicated and maybe even being set up for a lifetime of addiction.



Americans’ Prescription-Pill Use Skyrockets, Medco Report Finds

One in five women over the age of 20 is on antidepressants, men between 20 and 64 quadrupled their use of antipsychotics, and anti-anxiety-pill prescriptions for kids 10 to 19 are up 50 percent, according to a new Medco report. Casey Schwartz on the shocking findings.
Make no mistake about it—America is doped up to the gills.

Medco, the nationwide pharmacy-service company, released a report Wednesday laying out the prescription-pill habits of millions of Americans between 2001 and 2010.

Specifically, what the investigators at Medco focused on were “mental-health-related medications,” which fell into four categories: antidepressants, such as Prozac and Paxil; anti-anxiety pills, such as Xanax and Valium; ADHD pills, such as Ritalin and Adderall; and antipsychotics, including Seroquel, Resperadol, and Abilify.

And oh, how familiar these names have all become.

Gary Retherford / Getty Images

Among the many findings in the Medco report:

—In 2010, more than one in five adults was taking at least one of these drugs. That’s a 22 percent increase since 2001.

—Antidepressants are the most popular kind of mental-health medication. In 2010, 21 percent of American women over the age of 20 were prescribed one. For men, antidepressants are roughly half as common, but that number is changing. Twenty-eight percent more men were taking antidepressants in 2010 than in 2001.

—Although it’s women over 45 who take the greatest number of these drugs, it was young men, between 20 and 44 years old, who showed the greatest increase, jumping 43 percent since 2001.

—Eleven percent of middle-aged women are taking anti-anxiety medication, almost double the number of men who do, while kids between 10 and 19 years old increased their use of anti-anxiety pills by 50 percent from the start of the decade.

—Among children, more boys than girls are taking pills like Adderall and Ritalin for ADHD, but girls are gaining on them; 40 percent more girls were taking ADHD medications in 2010 than in 2001. Yet that increase, large as it is, is nothing compared with the increase for women in the 20-to-44 age range, for whom these meds were prescribed 264 percent more often in 2010 than in 2001.

—Men between 20 and 64 years old quadrupled their use of antipsychotics; women of the same age group more than tripled theirs.

Of all the study’s findings, psychiatrist David Muzina said he found the whopping increase in the use of these antipsychotic meds the most surprising—and most alarming.
But just because Americans are swallowing pills marked for specific disorders doesn’t mean they actually suffer from them. The Medco report tells us nothing about the diagnoses that went along with the prescriptions. Many, if not all, of the medications included in the Medco survey are routinely used for off-label purposes, performing functions other than those they originally were designed for.

For instance, antidepressants are now prescribed also for patients with fibromyalgia and anxiety disorders. Similarly, drugs known as “atypical antipsychotics,” such as Seroquel and Abilify, came on the market to treat psychosis but since have been adopted for the treatment of bipolar disorder as well as serving as an add-on drug in antidepressant regimens.

Dr. David Muzina, a psychiatrist who leads the Medco Neuroscience Therapeutic Resource Center, said that of all the study’s findings, he found the whopping increase in the use of these antipsychotic meds the most surprising—and most alarming.

Specifically, what concerns Muzina is their side effects. This class of drugs has been shown to raise blood lipids and significantly increase the risk of type II diabetes. It is strongly recommended that patients taking one of these drugs have, at minimum, a yearly blood workup to monitor glucose levels and lipids. Yet many patients and their physicians don’t comply with these guidelines, said Muzina. And so a “safety gap” opens up for the millions of Americans being dosed with Seroquel and its pharmaceutical siblings.

“My belief is that the report will surprise physicians and make them think whether or not their use is warranted,” he said.

The report provides information based solely on prescriptions being filled, so any theory about why a certain number has gone up or down is just a theory.

For the ADHD medications, such as Adderall and Ritalin, which have soared in popularity among Americans since 2001, the numbers could be misleading.

More boys than girls take these drugs in childhood, but more adult women than men were prescribed them in the last decade. The finding could be understood, said Muzina, in terms of how attention disorders present in girls, who often lack the “hyperactivity” that puts the H in ADHD. They might suffer from an attention disorder, but it’s not as conspicuous as it is in boys, so it may take until adulthood for women with ADHD to recognize the symptoms in themselves.

But this clearly isn’t the whole explanation. These drugs are taken on many American college campuses for their ability to keep students wired and focused around the clock.

“Frankly, the other component is that there’s some popularization of ADHD,” said Muzina, “and in America, we have a proclivity for the fast fix.”